Search research articles
Contact Us
Filters
Showing results (11-20 of 410) with videos related to
Page
of 41
Sort By:
AIDS (London, England)
|
June 24, 2003
Sometimes help may not be enough
Michael M Lederman, Daniel C Douek
Current Opinion in HIV and AIDS
|
April 18, 2009
The mucosal barrier and immune activation in HIV pathogenesis
Jason M Brenchley, Daniel C Douek
The Journal of Infectious Diseases
|
May 19, 2017
Perspectives on Human Immunodeficiency Virus (HIV) Cure: HIV Persistence in Tissue
Eli A Boritz, Daniel C Douek
Nature Reviews. Microbiology
|
August 14, 2012
Microbial translocation in HIV infection: causes, consequences and treatment opportunities
Netanya G Sandler, Daniel C Douek
Virologica Sinica
|
February 15, 2019
Manipulating the Interferon Signaling Pathway: Implications for HIV Infection
Krystelle Nganou-Makamdop, Daniel C Douek
Frontiers in Immunology
|
August 30, 2018
Beyond Hot Spots: Biases in Antibody Somatic Hypermutation and Implications for Vaccine Design
Chaim A Schramm, Daniel C Douek
Immunological Reviews
|
January 5, 2011
Vaccines
Daniel C Douek, Gary J Nabel
Cold Spring Harbor Perspectives in Medicine
|
January 10, 2012
Vaccine design for CD8 T lymphocyte responses
Richard A Koup, Daniel C Douek
Neurology
|
August 9, 2013
Risk factors for rare diseases can be risky to define: PML and natalizumab
Eugene O Major, Daniel C Douek
AIDS Research and Therapy
|
April 14, 2016
Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection
Camilla Tincati, Daniel C Douek, Giulia Marchetti
Page
of 41
Search research articles
Search
Showing results (11-20 of 410) with videos related to
Sort By:
Page
of 41
AIDS (London, England)
|
June 24, 2003
Sometimes help may not be enough
Michael M Lederman, Daniel C Douek
Current Opinion in HIV and AIDS
|
April 18, 2009
The mucosal barrier and immune activation in HIV pathogenesis
Jason M Brenchley, Daniel C Douek
The Journal of Infectious Diseases
|
May 19, 2017
Perspectives on Human Immunodeficiency Virus (HIV) Cure: HIV Persistence in Tissue
Eli A Boritz, Daniel C Douek
Nature Reviews. Microbiology
|
August 14, 2012
Microbial translocation in HIV infection: causes, consequences and treatment opportunities
Netanya G Sandler, Daniel C Douek
Virologica Sinica
|
February 15, 2019
Manipulating the Interferon Signaling Pathway: Implications for HIV Infection
Krystelle Nganou-Makamdop, Daniel C Douek
Frontiers in Immunology
|
August 30, 2018
Beyond Hot Spots: Biases in Antibody Somatic Hypermutation and Implications for Vaccine Design
Chaim A Schramm, Daniel C Douek
Immunological Reviews
|
January 5, 2011
Vaccines
Daniel C Douek, Gary J Nabel
Cold Spring Harbor Perspectives in Medicine
|
January 10, 2012
Vaccine design for CD8 T lymphocyte responses
Richard A Koup, Daniel C Douek
Neurology
|
August 9, 2013
Risk factors for rare diseases can be risky to define: PML and natalizumab
Eugene O Major, Daniel C Douek
AIDS Research and Therapy
|
April 14, 2016
Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection
Camilla Tincati, Daniel C Douek, Giulia Marchetti
Page
of 41